{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:36:52Z","timestamp":1789763812987,"version":"4.0.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:00:00Z","timestamp":1656115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:00:00Z","timestamp":1656115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s11033-022-07685-7","type":"journal-article","created":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T18:33:46Z","timestamp":1656182026000},"page":"10677-10687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Adenosine A2A receptor as a potential target for improving cancer immunotherapy"],"prefix":"10.1007","volume":"49","author":[{"given":"Muhammad","family":"Atif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Alsrhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farrah","family":"Naz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ikram","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman Ali Mohammed","family":"Alameen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6185-2042","authenticated-orcid":false,"given":"Hasan","family":"Ejaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,25]]},"reference":[{"key":"7685_CR1","volume-title":"Physiology, adenosine triphosphate","author":"J Dunn","year":"2022","unstructured":"Dunn J, Grider MH (2022) Physiology, adenosine triphosphate. StatPearls Publishing Copyright \u00a9 2022, StatPearls Publishing LLC, Treasure Island"},{"issue":"4","key":"7685_CR2","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.neuropharm.2011.12.001","volume":"62","author":"M Tautenhahn","year":"2012","unstructured":"Tautenhahn M, Leichsenring A, Servettini I, Pesic M, Sperlagh B, Norenberg W, Illes P (2012) Purinergic modulation of the excitatory synaptic input onto rat striatal neurons. Neuropharmacology 62(4):1756\u20131766. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.12.001","journal-title":"Neuropharmacology"},{"key":"7685_CR3","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3389\/fphar.2017.00898","volume":"8","author":"B Carpenter","year":"2017","unstructured":"Carpenter B, Lebon G (2017) Human adenosine A2A receptor: molecular mechanism of ligand binding and activation. Front Pharmacol 8:898. https:\/\/doi.org\/10.3389\/fphar.2017.00898","journal-title":"Front Pharmacol"},{"issue":"3","key":"7685_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nrd1983","volume":"5","author":"KA Jacobson","year":"2006","unstructured":"Jacobson KA, Gao Z-G (2006) Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5(3):247\u2013264. https:\/\/doi.org\/10.1038\/nrd1983","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"7685_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.110.003285","volume":"63","author":"BB Fredholm","year":"2011","unstructured":"Fredholm BB, IJzerman AP, Jacobson KA, Linden J, Muller CE (2011) International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors\u2013an update. Pharmacol Rev 63(1):1\u201334. https:\/\/doi.org\/10.1124\/pr.110.003285","journal-title":"Pharmacol Rev"},{"issue":"4","key":"7685_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2174\/1568026033392200","volume":"3","author":"BB Fredholm","year":"2003","unstructured":"Fredholm BB, Cunha RA, Svenningsson P (2003) Pharmacology of adenosine A2A receptors and therapeutic applications. Curr Top Med Chem 3(4):413\u2013426. https:\/\/doi.org\/10.2174\/1568026033392200","journal-title":"Curr Top Med Chem"},{"issue":"3","key":"7685_CR7","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","volume":"98","author":"PA Borea","year":"2018","unstructured":"Borea PA, Gessi S, Merighi S, Vincenzi F, Varani K (2018) Pharmacology of adenosine receptors: the state of the art. Physiol Rev 98(3):1591\u20131625. https:\/\/doi.org\/10.1152\/physrev.00049.2017","journal-title":"Physiol Rev"},{"issue":"4","key":"7685_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00702-019-01969-2","volume":"126","author":"DO Borroto-Escuela","year":"2019","unstructured":"Borroto-Escuela DO, Fuxe K (2019) Adenosine heteroreceptor complexes in the basal ganglia are implicated in Parkinson\u2019s disease and its treatment. J Neural Transm (Vienna) 126(4):455\u2013471. https:\/\/doi.org\/10.1007\/s00702-019-01969-2","journal-title":"J Neural Transm (Vienna)"},{"key":"7685_CR9","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1100\/tsw.2008.136","volume":"8","author":"G Navarro","year":"2008","unstructured":"Navarro G, Carriba P, Gandia J, Ciruela F, Casado V, Cortes A, Mallol J, Canela EI, Lluis C, Franco R (2008) Detection of heteromers formed by cannabinoid CB1, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer. Sci World J 8:1088\u20131097. https:\/\/doi.org\/10.1100\/tsw.2008.136","journal-title":"Sci World J"},{"issue":"3","key":"7685_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1113\/jphysiol.1929.sp002608","volume":"68","author":"AN Drury","year":"1929","unstructured":"Drury AN, Szent-Gyorgyi A (1929) The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol 68(3):213\u2013237. https:\/\/doi.org\/10.1113\/jphysiol.1929.sp002608","journal-title":"J Physiol"},{"issue":"4","key":"7685_CR11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1113\/jphysiol.1934.sp003095","volume":"80","author":"JH Gillespie","year":"1934","unstructured":"Gillespie JH (1934) The biological significance of the linkages in adenosine triphosphoric acid. J Physiol 80(4):345\u2013359. https:\/\/doi.org\/10.1113\/jphysiol.1934.sp003095","journal-title":"J Physiol"},{"issue":"1","key":"7685_CR12","first-page":"13","volume":"6","author":"A Sattin","year":"1970","unstructured":"Sattin A, Rall TW (1970) The effect of adenosine and adenine nucleotides on the cyclic adenosine 3\u2019, 5\u2019-phosphate content of guinea pig cerebral cortex slices. Mol Pharmacol 6(1):13\u201323","journal-title":"Mol Pharmacol"},{"issue":"1","key":"7685_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1113\/expphysiol.2013.071951","volume":"99","author":"G Burnstock","year":"2014","unstructured":"Burnstock G (2014) Purinergic signalling: from discovery to current developments. Exp Physiol 99(1):16\u201334. https:\/\/doi.org\/10.1113\/expphysiol.2013.071951","journal-title":"Exp Physiol"},{"issue":"5","key":"7685_CR14","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1471-4159.1979.tb05236.x","volume":"33","author":"D van Calker","year":"1979","unstructured":"van Calker D, Muller M, Hamprecht B (1979) Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem 33(5):999\u20131005. https:\/\/doi.org\/10.1111\/j.1471-4159.1979.tb05236.x","journal-title":"J Neurochem"},{"issue":"1","key":"7685_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/bf00734999","volume":"3","author":"JW Daly","year":"1983","unstructured":"Daly JW, Butts-Lamb P, Padgett W (1983) Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines. Cell Mol Neurobiol 3(1):69\u201380. https:\/\/doi.org\/10.1007\/bf00734999","journal-title":"Cell Mol Neurobiol"},{"issue":"5","key":"7685_CR16","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1073\/pnas.77.5.2551","volume":"77","author":"C Londos","year":"1980","unstructured":"Londos C, Cooper DM, Wolff J (1980) Subclasses of external adenosine receptors. Proc Natl Acad Sci USA 77(5):2551\u20132554. https:\/\/doi.org\/10.1073\/pnas.77.5.2551","journal-title":"Proc Natl Acad Sci USA"},{"key":"7685_CR17","doi-asserted-by":"crossref","unstructured":"Burnstock G (2006) Purinergic signaling\u2014an overview. Novartis Found Symp 276:26\u201348 (discussion 57, 275\u201381)","DOI":"10.1002\/9780470032244.ch4"},{"issue":"4","key":"7685_CR18","first-page":"331","volume":"29","author":"RF Bruns","year":"1986","unstructured":"Bruns RF, Lu GH, Pugsley TA (1986) Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol Pharmacol 29(4):331\u2013346","journal-title":"Mol Pharmacol"},{"key":"7685_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21145070","author":"A Lillo","year":"2020","unstructured":"Lillo A, Mart\u00ednez-Pinilla E, Reyes-Resina I, Navarro G, Franco R (2020) Adenosine A(2A) and A(3) receptors are able to interact with each other. A further piece in the puzzle of adenosine receptor-mediated signaling. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21145070","journal-title":"Int J Mol Sci"},{"issue":"3","key":"7685_CR20","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/s0006-291x(05)80909-x","volume":"173","author":"C Maenhaut","year":"1990","unstructured":"Maenhaut C, Van Sande J, Libert F, Abramowicz M, Parmentier M, Vanderhaegen JJ, Dumont JE, Vassart G, Schiffmann S (1990) RDC8 codes for an adenosine A2 receptor with physiological constitutive activity. Biochem Biophys Res Commun 173(3):1169\u20131178. https:\/\/doi.org\/10.1016\/s0006-291x(05)80909-x","journal-title":"Biochem Biophys Res Commun"},{"issue":"1\u20132","key":"7685_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/0169-328x(92)90152-2","volume":"15","author":"TJ Furlong","year":"1992","unstructured":"Furlong TJ, Pierce KD, Selbie LA, Shine J (1992) Molecular characterization of a human brain adenosine A2 receptor. Brain Res Mol Brain Res 15(1\u20132):62\u201366. https:\/\/doi.org\/10.1016\/0169-328x(92)90152-2","journal-title":"Brain Res Mol Brain Res"},{"issue":"1","key":"7685_CR22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/s0006-291x(05)90000-4","volume":"185","author":"Y Chern","year":"1992","unstructured":"Chern Y, King K, Lai HL, Lai HT (1992) Molecular cloning of a novel adenosine receptor gene from rat brain. Biochem Biophys Res Commun 185(1):304\u2013309. https:\/\/doi.org\/10.1016\/s0006-291x(05)90000-4","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"7685_CR23","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/bf00971338","volume":"19","author":"F Meng","year":"1994","unstructured":"Meng F, Xie GX, Chalmers D, Morgan C, Watson SJ Jr, Akil H (1994) Cloning and expression of the A2a adenosine receptor from guinea pig brain. Neurochem Res 19(5):613\u2013621. https:\/\/doi.org\/10.1007\/bf00971338","journal-title":"Neurochem Res"},{"issue":"6643","key":"7685_CR24","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/41771","volume":"388","author":"C Ledent","year":"1997","unstructured":"Ledent C, Vaugeois JM, Schiffmann SN, Pedrazzini T, El Yacoubi M, Vanderhaeghen JJ, Costentin J, Heath JK, Vassart G, Parmentier M (1997) Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388(6643):674\u2013678. https:\/\/doi.org\/10.1038\/41771","journal-title":"Nature"},{"issue":"2\u20133","key":"7685_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1385\/JMN:26:2-3:209","volume":"26","author":"K Fuxe","year":"2005","unstructured":"Fuxe K, Ferre S, Canals M, Torvinen M, Terasmaa A, Marcellino D, Goldberg SR, Staines W, Jacobsen KX, Lluis C, Woods AS, Agnati LF, Franco R (2005) Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function. J Mol Neurosci 26(2\u20133):209\u2013220. https:\/\/doi.org\/10.1385\/JMN:26:2-3:209","journal-title":"J Mol Neurosci"},{"issue":"2","key":"7685_CR26","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1124\/mol.104.003376","volume":"67","author":"M Torvinen","year":"2005","unstructured":"Torvinen M, Marcellino D, Canals M, Agnati LF, Lluis C, Franco R, Fuxe K (2005) Adenosine A2A receptor and dopamine D3 receptor interactions: evidence of functional A2A\/D3 heteromeric complexes. Mol Pharmacol 67(2):400\u2013407. https:\/\/doi.org\/10.1124\/mol.104.003376","journal-title":"Mol Pharmacol"},{"issue":"Suppl 1","key":"7685_CR27","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.neuropharm.2008.06.076","volume":"56","author":"S Ferre","year":"2009","unstructured":"Ferre S, Goldberg SR, Lluis C, Franco R (2009) Looking for the role of cannabinoid receptor heteromers in striatal function. Neuropharmacology 56(Suppl 1):226\u2013234. https:\/\/doi.org\/10.1016\/j.neuropharm.2008.06.076","journal-title":"Neuropharmacology"},{"issue":"18","key":"7685_CR28","doi-asserted-by":"publisher","first-page":"11940","DOI":"10.1073\/pnas.172393799","volume":"99","author":"S Ferre","year":"2002","unstructured":"Ferre S, Karcz-Kubicha M, Hope BT, Popoli P, Burgueno J, Gutierrez MA, Casado V, Fuxe K, Goldberg SR, Lluis C, Franco R, Ciruela F (2002) Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc Natl Acad Sci U S A 99(18):11940\u201311945. https:\/\/doi.org\/10.1073\/pnas.172393799","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"58","key":"7685_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fnagi.2016.00058","volume":"8","author":"J Zhao","year":"2016","unstructured":"Zhao J, Deng Y, Jiang Z, Qing H (2016) G protein-coupled receptors (GPCRs) in Alzheimer\u2019s disease: a focus on BACE1 related GPCRs. Front Aging Neurosci 8(58):58. https:\/\/doi.org\/10.3389\/fnagi.2016.00058","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"7685_CR30","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1046\/j.1471-4159.1996.66010362.x","volume":"66","author":"RA Peterfreund","year":"1996","unstructured":"Peterfreund RA, MacCollin M, Gusella J, Fink JS (1996) Characterization and expression of the human A2a adenosine receptor gene. J Neurochem 66(1):362\u2013368. https:\/\/doi.org\/10.1046\/j.1471-4159.1996.66010362.x","journal-title":"J Neurochem"},{"issue":"4","key":"7685_CR31","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1089\/dna.1996.15.329","volume":"15","author":"YY Chu","year":"1996","unstructured":"Chu YY, Tu KH, Lee YC, Kuo ZJ, Lai HL, Chern Y (1996) Characterization of the rat A2a adenosine receptor gene. DNA Cell Biol 15(4):329\u2013337. https:\/\/doi.org\/10.1089\/dna.1996.15.329","journal-title":"DNA Cell Biol"},{"issue":"12","key":"7685_CR32","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/s0895-7061(98)00166-6","volume":"11","author":"M Soma","year":"1998","unstructured":"Soma M, Nakayama T, Satoh M, Uwabo J, Rahmutula D, Takahashi Y, Fukuda N, Watanabe Y, Izumi Y, Kanmatsuse K (1998) A T1083C polymorphism in the human adenosine A2a receptor gene is not associated with essential hypertension. Am J Hypertens 11(12):1492\u20131494. https:\/\/doi.org\/10.1016\/s0895-7061(98)00166-6","journal-title":"Am J Hypertens"},{"issue":"2","key":"7685_CR33","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3390\/ijms15022024","volume":"15","author":"S Sheth","year":"2014","unstructured":"Sheth S, Brito R, Mukherjea D, Rybak LP, Ramkumar V (2014) Adenosine receptors: expression, function and regulation. Int J Mol Sci 15(2):2024\u20132052. https:\/\/doi.org\/10.3390\/ijms15022024","journal-title":"Int J Mol Sci"},{"issue":"9","key":"7685_CR34","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/cns.13190","volume":"25","author":"YJ Liu","year":"2019","unstructured":"Liu YJ, Chen J, Li X, Zhou X, Hu YM, Chu SF, Peng Y, Chen NH (2019) Research progress on adenosine in central nervous system diseases. CNS Neurosci Ther 25(9):899\u2013910. https:\/\/doi.org\/10.1111\/cns.13190","journal-title":"CNS Neurosci Ther"},{"key":"7685_CR35","doi-asserted-by":"publisher","first-page":"e10451","DOI":"10.7554\/eLife.10451","volume":"4","author":"K Xie","year":"2015","unstructured":"Xie K, Masuho I, Shih CC, Cao Y, Sasaki K, Lai CW, Han PL, Ueda H, Dessauer CW, Ehrlich ME, Xu B, Willardson BM, Martemyanov KA (2015) Stable G protein-effector complexes in striatal neurons: mechanism of assembly and role in neurotransmitter signaling. Elife 4:e10451. https:\/\/doi.org\/10.7554\/eLife.10451","journal-title":"Elife"},{"issue":"36","key":"7685_CR36","doi-asserted-by":"publisher","first-page":"25833","DOI":"10.1074\/jbc.274.36.25833","volume":"274","author":"MG Seidel","year":"1999","unstructured":"Seidel MG, Klinger M, Freissmuth M, Holler C (1999) Activation of mitogen-activated protein kinase by the A(2A)-adenosine receptor via a rap1-dependent and via a p21(ras)-dependent pathway. J Biol Chem 274(36):25833\u201325841. https:\/\/doi.org\/10.1074\/jbc.274.36.25833","journal-title":"J Biol Chem"},{"key":"7685_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20215475","author":"N Wolska","year":"2019","unstructured":"Wolska N, Rozalski M (2019) Blood platelet adenosine receptors as potential targets for anti-platelet therapy. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20215475","journal-title":"Int J Mol Sci"},{"issue":"3","key":"7685_CR38","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1124\/mol.58.3.477","volume":"58","author":"G Schulte","year":"2000","unstructured":"Schulte G, Fredholm BB (2000) Human adenosine A(1), A(2A), A(2B), and A(3) receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1\/2. Mol Pharmacol 58(3):477\u2013482. https:\/\/doi.org\/10.1124\/mol.58.3.477","journal-title":"Mol Pharmacol"},{"issue":"4","key":"7685_CR39","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/j.1538-7836.2010.03769.x","volume":"8","author":"D Yang","year":"2010","unstructured":"Yang D, Chen H, Koupenova M, Carroll SH, Eliades A, Freedman JE, Toselli P, Ravid K (2010) A new role for the A2b adenosine receptor in regulating platelet function. J Thromb Haemost 8(4):817\u2013827. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03769.x","journal-title":"J Thromb Haemost"},{"issue":"4","key":"7685_CR40","first-page":"524","volume":"39","author":"W Gross","year":"1991","unstructured":"Gross W, Lohse MJ (1991) Mechanism of activation of A2 adenosine receptors. II. A restricted collision-coupling model of receptor-effector interaction. Mol Pharmacol 39(4):524\u2013530","journal-title":"Mol Pharmacol"},{"key":"7685_CR41","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3389\/fphar.2019.00125","volume":"10","author":"VV Gurevich","year":"2019","unstructured":"Gurevich VV, Gurevich EV (2019) GPCR signaling regulation: the role of GRKs and arrestins. Front Pharmacol 10:125. https:\/\/doi.org\/10.3389\/fphar.2019.00125","journal-title":"Front Pharmacol"},{"issue":"1","key":"7685_CR42","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41467-022-28152-8","volume":"13","author":"J Drube","year":"2022","unstructured":"Drube J, Haider RS, Matthees ESF, Reichel M, Zeiner J, Fritzwanker S, Ziegler C, Barz S, Klement L, Filor J, Weitzel V, Kliewer A, Miess-Tanneberg E, Kostenis E, Schulz S, Hoffmann C (2022) GPCR kinase knockout cells reveal the impact of individual GRKs on arrestin binding and GPCR regulation. Nat Commun 13(1):540. https:\/\/doi.org\/10.1038\/s41467-022-28152-8","journal-title":"Nat Commun"},{"issue":"4","key":"7685_CR43","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1021\/bi962290v","volume":"36","author":"TM Palmer","year":"1997","unstructured":"Palmer TM, Stiles GL (1997) Identification of an A2a adenosine receptor domain specifically responsible for mediating short-term desensitization. Biochemistry 36(4):832\u2013838. https:\/\/doi.org\/10.1021\/bi962290v","journal-title":"Biochemistry"},{"issue":"5","key":"7685_CR44","first-page":"861","volume":"45","author":"CE Piersen","year":"1994","unstructured":"Piersen CE, True CD, Wells JN (1994) A carboxyl-terminally truncated mutant and nonglycosylated A2a adenosine receptors retain ligand binding. Mol Pharmacol 45(5):861\u2013870","journal-title":"Mol Pharmacol"},{"issue":"36","key":"7685_CR45","doi-asserted-by":"publisher","first-page":"32490","DOI":"10.1074\/jbc.M200556200","volume":"277","author":"M Klinger","year":"2002","unstructured":"Klinger M, Kudlacek O, Seidel MG, Freissmuth M, Sexl V (2002) MAP kinase stimulation by cAMP does not require RAP1 but SRC family kinases. J Biol Chem 277(36):32490\u201332497. https:\/\/doi.org\/10.1074\/jbc.M200556200","journal-title":"J Biol Chem"},{"issue":"12","key":"7685_CR46","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.3390\/ijms21124547","volume":"21","author":"AR Jain","year":"2020","unstructured":"Jain AR, Robinson AS (2020) Functional expression of adenosine A(3) receptor in yeast utilizing a chimera with the A(2A)R C-terminus. Int J Mol Sci 21(12):4547. https:\/\/doi.org\/10.3390\/ijms21124547","journal-title":"Int J Mol Sci"},{"issue":"4","key":"7685_CR47","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1124\/mol.105.015818","volume":"69","author":"T Milojevic","year":"2006","unstructured":"Milojevic T, Reiterer V, Stefan E, Korkhov VM, Dorostkar MM, Ducza E, Ogris E, Boehm S, Freissmuth M, Nanoff C (2006) The ubiquitin-specific protease Usp4 regulates the cell surface level of the A2A receptor. Mol Pharmacol 69(4):1083\u20131094. https:\/\/doi.org\/10.1124\/mol.105.015818","journal-title":"Mol Pharmacol"},{"key":"7685_CR48","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fcell.2019.00043","volume":"7","author":"JC Burton","year":"2019","unstructured":"Burton JC, Grimsey NJ (2019) Ubiquitination as a key regulator of endosomal signaling by GPCRs. Front Cell Dev Biol 7:43. https:\/\/doi.org\/10.3389\/fcell.2019.00043","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"7685_CR49","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1083\/jcb.200602082","volume":"173","author":"SM Millard","year":"2006","unstructured":"Millard SM, Wood SA (2006) Riding the DUBway: regulation of protein trafficking by deubiquitylating enzymes. J Cell Biol 173(4):463\u2013468. https:\/\/doi.org\/10.1083\/jcb.200602082","journal-title":"J Cell Biol"},{"issue":"6","key":"7685_CR50","doi-asserted-by":"publisher","first-page":"7204","DOI":"10.18632\/oncotarget.23208","volume":"9","author":"L Chen","year":"2018","unstructured":"Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L (2018) Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9(6):7204\u20137218. https:\/\/doi.org\/10.18632\/oncotarget.23208","journal-title":"Oncotarget"},{"key":"7685_CR51","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3389\/fimmu.2014.00304","volume":"5","author":"A Ohta","year":"2014","unstructured":"Ohta A, Sitkovsky MJFii, (2014) Extracellular adenosine-mediated modulation of regulatory T cells. Front Immunol 5:304. https:\/\/doi.org\/10.3389\/fimmu.2014.00304","journal-title":"Front Immunol"},{"issue":"S1","key":"7685_CR52","doi-asserted-by":"publisher","first-page":"S457","DOI":"10.1038\/bjp.2008.23","volume":"153","author":"M Sitkovsky","year":"2008","unstructured":"Sitkovsky M, Lukashev D, Deaglio S, Dwyer K, Robson S, Ohta AJB (2008) Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells. Br J Pharmacol 153(S1):S457\u2013S464. https:\/\/doi.org\/10.1038\/bjp.2008.23","journal-title":"Br J Pharmacol"},{"issue":"35","key":"7685_CR53","doi-asserted-by":"publisher","first-page":"13132","DOI":"10.1073\/pnas.0605251103","volume":"103","author":"A Ohta","year":"2006","unstructured":"Ohta A, Gorelik E, Prasad SJ, Ronchese F, Lukashev D, Wong MK, Huang X, Caldwell S, Liu K, Smith P (2006) A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci USA 103(35):13132\u201313137. https:\/\/doi.org\/10.1073\/pnas.0605251103","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"7685_CR54","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrc.2017.110","volume":"17","author":"D Vijayan","year":"2017","unstructured":"Vijayan D, Young A, Teng MW, Smyth MJJNRC (2017) Targeting immunosuppressive adenosine in cancer. Nat Rev Cancer 17(12):709\u2013724. https:\/\/doi.org\/10.1038\/nrc.2017.110","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"7685_CR55","doi-asserted-by":"publisher","first-page":"e000417","DOI":"10.1136\/jitc-2019-000417","volume":"8","author":"A Borodovsky","year":"2020","unstructured":"Borodovsky A, Barbon CM, Wang Y, Ye M, Prickett L, Chandra D, Shaw J, Deng N, Sachsenmeier K, Clarke JDJJ (2020) Small molecule AZD4635 inhibitor of A2AR signaling rescues immune cell function including CD103+ dendritic cells enhancing anti-tumor immunity. J Immunother Cancer 8(2):e000417. https:\/\/doi.org\/10.1136\/jitc-2019-000417","journal-title":"J Immunother Cancer"},{"issue":"1","key":"7685_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.110.003285","volume":"63","author":"BB Fredholm","year":"2011","unstructured":"Fredholm BB, IJzerman AP, Jacobson KA, Linden J, M\u00fcller CE (2011) International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors\u2013an update. Pharmacol Rev 63(1):1\u201334. https:\/\/doi.org\/10.1124\/pr.110.003285","journal-title":"Pharmacol Rev"},{"issue":"4","key":"7685_CR57","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nri3405","volume":"13","author":"L Chen","year":"2013","unstructured":"Chen L, Flies DBJNRI (2013) Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 13(4):227\u2013242. https:\/\/doi.org\/10.1038\/nri3405","journal-title":"Nat Rev Immunol"},{"key":"7685_CR58","doi-asserted-by":"publisher","first-page":"570041","DOI":"10.3389\/fimmu.2020.570041","volume":"11","author":"JM Steingold","year":"2020","unstructured":"Steingold JM, Hatfield SMJF (2020) Targeting hypoxia-A2A adenosinergic immunosuppression of antitumor T cells during cancer immunotherapy. Front Immunol 11:570041. https:\/\/doi.org\/10.3389\/fimmu.2020.570041","journal-title":"Front Immunol"},{"issue":"1","key":"7685_CR59","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1038\/s41467-021-23331-5","volume":"12","author":"L Giuffrida","year":"2021","unstructured":"Giuffrida L, Sek K, Henderson MA, Lai J, Chen AX, Meyran D, Todd KL, Petley EV, Mardiana S, M\u00f8lck CJN (2021) CRISPR\/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy. Nat Commun 12(1):3236. https:\/\/doi.org\/10.1038\/s41467-021-23331-5","journal-title":"Nat Commun"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07685-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07685-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07685-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T19:13:49Z","timestamp":1700766829000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07685-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,25]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["7685"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07685-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,25]]},"assertion":[{"value":"26 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}